ATP has been shown to modulate progesterone production in human granulosa-luteal cells (hGLCs) in vitro. After binding to a G protein-coupled P2 purinergic receptor, ATP stimulates phospholipase C. The resultant production of diacylglycerol and inositol triphosphate activates protein kinase C (PKC) and intracellular calcium [Ca 2ϩ ] i mobilization, respectively. In the present study, we examined the potential cross-talk between the PKC and Ca 2ϩ pathway in ATP signal transduction. Specifically, the effect of PKC on regulating ATP-evoked [Ca 2ϩ ] i oscillations were examined in hGLCs. Using microspectrofluorimetry, [Ca 2ϩ ] i oscillations were detected in Fura-2 loaded hGLCs in primary culture. The amplitudes of the ATPtriggered [Ca 2ϩ ] i oscillations were reduced in a dose-dependent manner by pretreating the cells with various concentrations (1 nM to 10 M) of the PKC activator, phorbol-12-myristate-13-acetate (PMA). A 10 M concentration of PMA completely suppressed 10 M ATPinduced oscillations. The inhibitory effect occurred even when PMA was given during the plateau phase of ATP evoked [Ca 2ϩ ] i oscillations, suggesting that extracellular calcium influx was inhibited. The role of PKC was further substantiated by the observation that, in the presence of a PKC inhibitor, bisindolylmaleimide I, ATP-induced [Ca 2ϩ ] i oscillations were not completely suppressed by PMA. Furthermore, homologous desensitization of ATP-induced calcium oscillations was partially reversed by bisindolylmaleimide I, suggesting that activated PKC may be involved in the mechanism of desensitization. These results demonstrate that PKC negatively regulates the ATP-evoked [Ca 2ϩ ] i mobilization from both intracellular stores and extracellular influx in hGLCs and further support a modulatory role of ATP and P2 purinoceptor in ovarian steroidogenesis. (J Clin Endocrinol Metab 86: 773-777, 2001) 
] i oscillations, suggesting that extracellular calcium influx was inhibited. The role of PKC was further substantiated by the observation that, in the presence of a PKC inhibitor, bisindolylmaleimide I, ATP-induced [Ca 2ϩ ] i oscillations were not completely suppressed by PMA. Furthermore, homologous desensitization of ATP-induced calcium oscillations was partially reversed by bisindolylmaleimide I, suggesting that activated PKC may be involved in the mechanism of desensitization. These results demonstrate that PKC negatively regulates the ATP-evoked [Ca 2ϩ ] i mobilization from both intracellular stores and extracellular influx in hGLCs and further support a modulatory role of ATP and P2 purinoceptor in ovarian steroidogenesis. (J Clin Endocrinol Metab 86: [773] [774] [775] [776] [777] 2001) A TP, RELEASED FROM autonomic nerves by exocytosis, activates phospholipase C (PLC) through binding to a G protein-coupled P2 purinoceptors. This activation leads to the production of diacylglycerol and inositol 1,4,5-triphosphate, which in turn activates protein kinase C (PKC) and mobilizes intracellular calcium ([Ca 2ϩ ] i ), respectively (1, 2) . Through this signaling pathway, ATP may participate in various types of physiological responses, including secretion, membrane potential, cell proliferation, platelet aggregation, neurotransmission, cardiac function, and muscle contraction (3, 4) .
PKC, a serine-threonine kinase that can be activated by tumor-promoting phorbol esters, has been shown to play a key role in intracellular signaling and regulate a wide range of cell functions (5, 6) . In many systems, PKC has been shown to regulate calcium channel activity and modulate calcium signaling pathway (6 -8) . In the ovary, activated PKC has been reported to alter ATP-triggered intracellular calcium oscillations in chicken granulosa cells (9) and inhibit steroidogenesis in swine granulosa cells (10) . Recently, ATP has been shown to evoke calcium oscillations and regulate steroidogenesis in human granulosa cells (11) (12) (13) . However, the cross-talk between the ATP-triggered PKC and Ca 2ϩ signaling pathways in the human ovary is not understood. The present study was designed to examine the potential effect of PKC in the regulation of ATP-trigger calcium oscillations in human granulosa-luteal cells (hGLCs). As well, the role of PKC in the homologous desensitization of ATP-triggered calcium oscillations was investigated.
Materials and Methods

Reagents and materials
ATP and phorbol-12-myristate-13-acetate (PMA) were obtained from Sigma (St. Louis, MO). DMEM, penicillin-streptomycin, and FBS were purchased from Life Technologies, Inc. (Burlington, Ontario, Canada). Fura-2 AM was purchased from Molecular Probes, Inc. (Eugene, OR). bisindolylmaleimide I, a PKC inhibitor, was obtained from Calbiochem (Cedarlane, Ontario, Canada).
hGLCs in culture hGLCs were collected from patients undergoing In Vitro FertilizationEmbryo Transfer (IVF-ET) program. The use of hGLCs is approved by UBC Clinical Screening Committee for Research and Other Studies Involving Human Subjects. Granulosa cells were separated from red blood cells in follicular aspirates by centrifugation through Ficoll Paque, then washed and suspended in DMEM containing 100 U penicillin G sodium/ml, 100 g streptomycin/ml and 10% heat-inactivated FBS, as described before (12) . hGLCs were seeded onto 25-mm circular glass cover slips (5,000 cells/slip) and incubated for 3 days at 37 C in humidified air with 5% CO 2 before microfluorimetric experiments.
Microspectrofluorimetry
Cytosolic calcium concentrations were measured using the dualexcitation single-emission fluorometric technique, as described previously (12) . Briefly, the cells were incubated with 5-10 m fura-2 AM acetoxymethyl ester for 30 min at 37 C in humidified air with 5% CO 2 . The coverslip was mounted onto the perifusion chamber and equilibrated for 10 min with balanced salt buffer (137 mm NaCl, 5.36 mm KCl, 1.26 mm CaCl2, 0.81 mm MgSO 4 ⅐7H 2 O, 0.34 mm Na 2 HPO 4 ⅐7H 2 O, 0.44 mm KH2PO4, 4.17 mm NaHCO3, 10 mm HEPES, 2.02 mm glucose, pH 7.4) in humidified air with 5% CO 2 . The fura-2 ratio measurements were performed using the Attoflour Digital Fluorescence Microscopy System (Atto Instruments, Rockville, MD). The perifusion chamber was connected to a multiunit six-channel perifusion system with a flow rate of 1-2 mL/min. Fura-2 loaded cells were observed through a 40ϫ fluorescent objective lens and illuminated alternatively with light at 340 nm and 380 nm. Emitted light was filtered using a 510 nm long-pass filter and detected using a low light sensitive camera. Measurements of cytosolic calcium were performed at 1-2 sec intervals. All records were normalized for background fluorescence (determined from cell-free region of cover slip). Changes in the fluorescence ratio recorded at 340 and 380 nm correspond to changes in cytosolic calcium.
Treatments
To examine the effect of ATP on inducing intracellular calcium oscillations, hGLCs were treated with various concentrations of ATP (1, 10, or 100 m) before cytosolic calcium determinations on day 3. Further, hGLCs were cultured for various days (3, 5, or 7 days) before 10 m ATP treatment.
To investigate the effect of PKC on regulating ATP-triggered calcium oscillations, hGLCs were treated with various concentrations of PKC activator, phorbol-12-myristate-13-acetate (PMA) (1, 10, 100 nm, 1 or 10 m) for 5 min, followed by treatment with 10 m ATP for 3 min.
To further investigate the role of PKC in the regulation of ATPinduced calcium oscillations, hGLCs were pretreated with 1 m bisindolylmaleimide I, a PKC inhibitor (14) , for 2 min before PMA and ATP stimulation as performed in the previous experiments.
It has been demonstrated that the intracellular calcium changes are initiated by the release of calcium from cytosolic stores and followed by extracellular calcium influx. To examine whether PKC affects the calcium influx in ATP-evoked calcium mobilization, cells were treated with PMA during the plateau phase of calcium oscillations.
To examine the role of PKC in homologous desensitization of ATPevoked calcium oscillations, PMA was administered between two ATP treatments. In addition, hGLCs were treated repeatedly with ATP in the absence or presence of Bisindolylmaleimide I.
Data analysis
Data were shown as means of three individual experiments and presented as the mean Ϯ sd. The data were analyzed by one-way ANOVA followed by Tukey test. Data were considered significant when P Ͻ 0.05.
Results
Induction of cytosolic calcium oscillations by ATP in hGLCs
hGLCs were treated with various concentrations of ATP (1, 10, or 100 m) for 3 min. Our results showed that ATP triggered calcium oscillations in these cells (Fig. 1A) . The response to ATP was characterized by a spike and a marked increase in cytosolic calcium, followed by numerous oscillations with decreasing amplitudes to preactivated levels. As shown in Fig. 1A , ATP induced cytosolic mobilization in a dose-dependent manner, with maximal response reached when treated with 10 m of ATP, and no difference was noted between cells treated with 10 m and 100 m. Figure  1B demonstrated the effects of 10 m ATP on inducing calcium mobilization in hGLCs with various culturing days.
There were no significant difference in both of the patterns and amplitudes of ATP-evoked calcium oscillations.
The role of PKC in ATP-triggered calcium oscillations in hGLCs
To determine the role of activated PKC in ATP-triggered calcium oscillations, hGLCs were pretreated with increasing concentrations of PKC activator, PMA (1 nm, 10 nm, 100 nm, 1 m, or 10 m) for 5 min, and then stimulated with 10 m ATP. As shown in Fig. 2 , PMA pretreatment reduced the amplitudes of ATP-induced calcium oscillations in a dosedependent manner. Complete inhibition of initial [Ca 2ϩ ] i spike was noted when cells were pretreated with 10 m PMA.
To further examine the role of PKC in the regulation of ATP-triggered calcium oscillations, Fura-2 loaded hGLCs were pretreated in sequence with 1 m bisindolylmaleimide I for 2 min, and Bisindolylmaleimide I plus 10 m PMA for 5 min, before treatment of 10 m ATP. The results revealed that, in contrast to pretreatment with PMA alone (Fig. 2F) , ATP induced calcium oscillations when the cells were pretreated with both PMA and the PKC inhibitor (Fig. 3) .
To examine whether PMA affects the calcium influx in ATP-evoked calcium mobilization, cells were treated with PMA during the plateau phase of ATP-triggered calcium oscillations. The result, when compared with control (Fig.  4A) , demonstrated that the amplitudes of calcium oscillations of PMA-treated cells declined to baseline level abruptly (Fig. 4B) , suggesting that calcium influx was inhibited by activated PKC. 
The role of PKC in homologous desensitization of ATPtriggered calcium oscillations in hGLCs
Calcium replacement is required to maintain cytosolic calcium oscillations during repeated ATP treatments (13) . In the present study, treatment of hGLCs with PMA completely suppressed the subsequent ATP-induced calcium oscillations (Fig. 5A) , suggesting that activated PKC may play a role in mediating homologous desensitization. In addition, calcium oscillations were partially reversed during subsequent exposures of hGLCs to ATP in the presence of bisindolylmaleimide I (Fig. 5C ), when compared with repeated ATP exposures in the absence of bisindolylmaleimide I (Fig, 5B) , supporting the proposal that PKC may be involved in homologous desensitization of ATP-triggered calcium oscillations.
Discussion
ATP, released from nerve endings, has been shown to participate in various types of physiological responses (3, 4, (15) (16) (17) . It is tempting to speculate that the coreleased ATP from autonomic nerve endings in the ovary may play a role in regulating ovarian function. ATP has been shown to regulate the production of progesterone and estradiol in hGLCs (11) . We have reported previously that the P2U purinoceptor is expressed in hGLCs (18) , further supporting a physiological role of ATP in the human ovary.
Calcium, a second messenger, has been shown to mediate several physiological activities including fertilization, em- bryo development, cell proliferation, and cell death (19) . As demonstrated in this study, ATP is able to mobilize cytosolic calcium, implicating a role of ATP in the control of ovarian function. This finding leads us to postulate that several calcium-dependent kinases such as PKC or Ca 2ϩ /calmodulindependent protein kinase (20) may be involved in regulating cellular function. However, the precise role of calcium oscillations is not clear yet (8) . PKC has been reported to modulate the activities of ion channels including calcium channels and potassium channels (21) . In addition, PKC has been shown to modulate cytosolic calcium and cAMP levels induced by activation of P2U-purinergic receptor on rat glioma cells (22) . In the ovary, PKC has been reported to modulate ATP-evoked calcium oscillation in chicken granulosa cells, supporting the notion that the calcium oscillations were reduced by either activation or inhibition of PKC activity (9) . In the present study, a role of PKC in regulating ATPinduced calcium oscillations was revealed in hGLCs. Our results demonstrate that the activation of PKC activity negatively regulated the ATP-evoked cytosolic calcium mobilization from both intracellular stores and extracellular influx in cultured hGLCs. Pretreatment with a PKC inhibitor reversed the inhibitory effect of activated PKC, further supporting the role of PKC in ATP-evoked calcium oscillations in the human ovary.
ATP has been shown to effect a homologous desensitization of ATP-receptor (23) . Homologous desensitization is characterized by a reduced response to an agonist due to repeated treatments with the same agonist. It has been suggested that PKC activated by agonists may be involved in the mechanism of desensitization in several studies (23) (24) (25) . ATP-evoked calcium oscillations are dependent upon calcium mobilizations from both cytosolic stores and extracellular influx. Calcium replacement is required to maintain cytosolic calcium oscillations during repeated ATP treatments (13) . However, the calcium replacement still cannot prevent the down-regulation of the amplitudes of oscillations during repeated ATP treatments, implying that another regulator exists. Several other studies have linked this type of desensitization with activated PKC (22, 26) . In many systems, PKC has been shown to regulate calcium channel activity and modulate calcium signaling pathway (6 -8) . In the present study, repeated treatment of ATP decreased the amplitudes of initial spike of calcium oscillations, which can be partially reversed by pretreatment with PKC inhibitor. This result indicates that PKC mediates ATP-induced homologous desensitization in calcium oscillations in hGLCs.
The mechanism of PKC in regulating calcium oscillations is not clear. Several proteins in the ATP signal transduction pathway can be proposed to act as potential targets of activated PKC. Considering several potential phosphorylation sites in P2U purinoceptor (27) , the P2U purinoceptor function may be affected by activated PKC (Fig. 6, arrow 1) . This proposal is supported by the finding that phorbol ester, a PKC activator, can inhibit the function of G protein-coupled receptor (28, 29) . With respect to receptor-coupled G proteins, several studies have shown that phorbol ester can regulate G protein-mediated responses (30 -32) , indicating that P2UR-coupled G protein may be inhibited by activated PKC in hGLCs (Fig. 6, arrow 2] ). In addition, activated PKC has been identified to attenuate agonist-induced inositol phospholipid hydrolysis (33) (34) (35) , suggesting that agoniststimulated phospholipase C may be desensitized through a negative feedback involving the activation of PKC (Fig. 6,  arrow 3 ). Inositol triphosphate (IP3), a product of inositol phospholipid hydrolysis, binds to IP3 receptors on endoplasmic reticulum and induces the release of calcium from the intracellular stores. PKC has been shown to phosphorylate a serine site on IP3 receptors (36, 37) , implying that activated PKC may shutdown cytosolic calcium mobilization through inactivation of the function of IP3 receptor (Fig. 6,  arrow 4) . Calcium influx from the extracellular environment plays a critical role in maintaining the plateau phase following an initial peak of cytosolic calcium oscillations (12) . PKC has been demonstrated to down-regulate or alter calcium influx in agonist-induced calcium mobilization in different systems (21, 38 -40) (Fig. 6, arrow 5] ). Based on above findings, it can be proposed that the ATP-activated PKC may feedback at different levels intracellularly, including the P2U purinoceptor, G protein-coupled, phospholipase C, IP3 receptor, or calcium channel, culminating in a shutdown of the calcium signaling pathway in hGLCs.
In conclusion, our results demonstrated that 1) ATP was capable of inducing calcium oscillation in hGLCs in a dosedependent manner; 2) PKC negatively regulated the ATPevoked [Ca 2ϩ ] i mobilization from both intracellular stores and extracellular influx in cultured hGLCs; and 3) PKC was involved in ATP-induced homologous desensitization in hGLCs. Taken together, these results indicate that ATP may exert a feedback regulation on its own signaling pathway through activation of PKC in the human ovary.
